Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis

SIMPLE SUMMARY: Bile duct cancer (cholangiocarcinoma) is a relatively rare cancer type that has a 5-year survival rate of 26% if diagnosed early, but a survival rate of less than 10% if the cancer has spread to the lymph nodes. Most patients with bile duct cancer are treated with surgery and chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jiyoung, Nam, Gilyeong, Shin, You Keun, Vilaplana-Lopera, Nuria, Jeung, Hei-Cheul, Moon, Eui Jung, Lee, Ik Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047303/
https://www.ncbi.nlm.nih.gov/pubmed/36980768
http://dx.doi.org/10.3390/cancers15061882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047303/
https://www.ncbi.nlm.nih.gov/pubmed/36980768
http://dx.doi.org/10.3390/cancers15061882

Ejemplares similares